Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 2 Results

Intervention Indication Therapeutic Area Year Actions
Esketamine (nasal spray) for major depressive disorder with imminent risk of suicide Esketamine (JNJ-54135419; Keyzilen; AM-101; esketamine hydrochloride) Major depressive disorder (MDD) Mental and Behavioural Health 2019 View  |  Download
Esketamine for Treatment-resistant Depression Esketamine (JNJ-54135419; Keyzilen; AM-101; esketamine hydrochloride) Depression Mental and Behavioural Health 2017 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications